chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood thyroid stimulating hormone increased, Electrocardiogram normal, Full blood count normal, Myocardial necrosis marker normal, Oropharyngeal discomfort
Clinical narrative: The vaccine was given to me. Within 5 minutes my throat felt strange so I went get water. I went pale and blood pressure was 205/198 along with tachycardia. Spent hours in E.R.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pallor, Tachycardia
Clinical narrative: The vaccine was given to me. Within 5 minutes my throat felt strange so I went get water. I went pale and blood pressure was 205/198 along with tachycardia. Spent hours in E.R.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymph node pain, Neck pain, Pain in extremity
Clinical narrative: Minimal arm soreness in left arm/left forearm pain; supraclavicular lymph node (left side, mildly tender); left anterior neck pain (mild); Anaphylaxis; This is a spontaneous report from a contactable nurse (patient). A 44-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELO 140), via an unspecified route of administration in the left arm on 11Jan2021 16:00 at a single dose for covid-19 immunization. Medical history included known allergies: blue crab. Concomitant medication included unspecified over-the-counter multivitamins for women. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on unspecified date for covid-19 immunization. It was reported that the patient is not pregnant. The patient was not diagnosed with covid-19 prior to vaccination. The patient was not tested for covid-19 post vaccination. On unspecified date in Jan2021, the patient experienced anaphylaxis. On 14Jan2021 0700, the patient experienced minimal arm soreness in left arm. On unspecified date in Jan2021, the patient experienced supraclavicular lymph node (left side, mildly tender), left anterior neck pain (mild), and left forearm pain (mild). The patient had no fever and no other symptoms at this time. No treatment was received for the events Minimal arm soreness in left arm/left forearm pain, supraclavicular lymph node (left side, mildly tender), left anterior neck pain (mild). Outcome of the event Minimal arm soreness in left arm/left forearm pain was recovered on unspecified date in Jan2021. Outcome of the event anaphylaxis was unknown. Outcome of the events supraclavicular lymph node (left side, mildly tender) and left anterior neck pain (mild) was not recovered.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset of anaphylaxis cannot be excluded, considering the plausible temporal relationship and the known adverse event profile of the suspect product.  Severe allergic reaction is the known risk for the product.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Lymph node pain, Lymphadenopathy, Neck pain, Pain in extremity
Clinical narrative: Minimal arm soreness in left arm/left forearm pain; supraclavicular lymph node (left side, mildly tender); left anterior neck pain (mild); Anaphylaxis; This is a spontaneous report from a contactable nurse (patient). A 44-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELO 140), via an unspecified route of administration in the left arm on 11Jan2021 16:00 at a single dose for covid-19 immunization. Medical history included known allergies: blue crab. Concomitant medication included unspecified over-the-counter multivitamins for women. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on unspecified date for covid-19 immunization. It was reported that the patient is not pregnant. The patient was not diagnosed with covid-19 prior to vaccination. The patient was not tested for covid-19 post vaccination. On unspecified date in Jan2021, the patient experienced anaphylaxis. On 14Jan2021 0700, the patient experienced minimal arm soreness in left arm. On unspecified date in Jan2021, the patient experienced supraclavicular lymph node (left side, mildly tender), left anterior neck pain (mild), and left forearm pain (mild). The patient had no fever and no other symptoms at this time. No treatment was received for the events Minimal arm soreness in left arm/left forearm pain, supraclavicular lymph node (left side, mildly tender), left anterior neck pain (mild). Outcome of the event Minimal arm soreness in left arm/left forearm pain was recovered on unspecified date in Jan2021. Outcome of the event anaphylaxis was unknown. Outcome of the events supraclavicular lymph node (left side, mildly tender) and left anterior neck pain (mild) was not recovered.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset of anaphylaxis cannot be excluded, considering the plausible temporal relationship and the known adverse event profile of the suspect product.  Severe allergic reaction is the known risk for the product.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: C-reactive protein increased, Chest X-ray, Fatigue, Full blood count, Metabolic function test
Clinical narrative: Fevers up to 103 F, chills, malaise, myalgia  7 days after vaccination received.  CBC with normal WBC but elevated neutrophils and decreased lymphocytes.  Elevated AST and ALT into 60s.  CRP elevated to 145.  Placed on prednisone burst daily x 5 days 9 days after receiving vaccination.  Symptoms improved but have not yet resolved as of today.  Temp today is 99.3 F.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, Urine analysis
Clinical narrative: Fevers up to 103 F, chills, malaise, myalgia  7 days after vaccination received.  CBC with normal WBC but elevated neutrophils and decreased lymphocytes.  Elevated AST and ALT into 60s.  CRP elevated to 145.  Placed on prednisone burst daily x 5 days 9 days after receiving vaccination.  Symptoms improved but have not yet resolved as of today.  Temp today is 99.3 F.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase, C-reactive protein increased, Chest X-ray normal, Differential white blood cell count normal
Clinical narrative: Fevers up to 103 F, chills, malaise, myalgia  7 days after vaccination received.  CBC with normal WBC but elevated neutrophils and decreased lymphocytes.  Elevated AST and ALT into 60s.  CRP elevated to 145.  Placed on prednisone burst daily x 5 days 9 days after receiving vaccination.  Symptoms improved but have not yet resolved as of today.  Temp today is 99.3 F.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Full blood count normal, Pain, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Fevers up to 103 F, chills, malaise, myalgia  7 days after vaccination received.  CBC with normal WBC but elevated neutrophils and decreased lymphocytes.  Elevated AST and ALT into 60s.  CRP elevated to 145.  Placed on prednisone burst daily x 5 days 9 days after receiving vaccination.  Symptoms improved but have not yet resolved as of today.  Temp today is 99.3 F.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, C-reactive protein increased, Chills, Differential white blood cell count normal
Clinical narrative: Fevers up to 103 F, chills, malaise, myalgia  7 days after vaccination received.  CBC with normal WBC but elevated neutrophils and decreased lymphocytes.  Elevated AST and ALT into 60s.  CRP elevated to 145.  Placed on prednisone burst daily x 5 days 9 days after receiving vaccination.  Symptoms improved but have not yet resolved as of today.  Temp today is 99.3 F.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Full blood count, Lymphocyte count decreased, Malaise, Myalgia, Neutrophil count increased
Clinical narrative: Fevers up to 103 F, chills, malaise, myalgia  7 days after vaccination received.  CBC with normal WBC but elevated neutrophils and decreased lymphocytes.  Elevated AST and ALT into 60s.  CRP elevated to 145.  Placed on prednisone burst daily x 5 days 9 days after receiving vaccination.  Symptoms improved but have not yet resolved as of today.  Temp today is 99.3 F.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Fevers up to 103 F, chills, malaise, myalgia  7 days after vaccination received.  CBC with normal WBC but elevated neutrophils and decreased lymphocytes.  Elevated AST and ALT into 60s.  CRP elevated to 145.  Placed on prednisone burst daily x 5 days 9 days after receiving vaccination.  Symptoms improved but have not yet resolved as of today.  Temp today is 99.3 F.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Computerised tomogram, Dyspnoea, Echocardiogram, Laboratory test
Clinical narrative: Persistent shortness of breath; Chest pain; Runny nose; Dry cough; Dizzy; This is a spontaneous report from a contactable other healthcare professional (patient). A 37-year-old female patient received the second dose of bnt162b2 (COVID-19 vaccine, brand: Pfizer) via an unspecified route of administration in right arm, on 07Jan2021 09:15 at a single dose for COVID-19 immunization in a hospital. Medical history included narcolepsy from an unknown date and unknown if ongoing and ongoing persistent shortness of breath from an unknown date. No known allergy. Concomitant medication included armodafinil, sertraline hydrochloride (ZOLOFT), and dextroamphetamine (DEXAMFETAMINE). The patient previously received the first dose of bnt162b2 on 21Dec2020 12:00 in right arm for COVID-19 immunization at age 37 years old. The patient had no COVID prior to vaccination. On 07Jan2021, the patient experienced shortness of breath, chest pain, runny nose, dry cough, dizzy. The patient had 2 ER visits and admission, and ongoing work up. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization for 1 day. The patient received albuterol and alprazolam (XANAX) as treatment. The patient underwent covid test post vaccination: Nasal swab on 11Jan2021 and on 12Jan2021 with both with result negative. The patient had not recovered from the events.  Information on the lot/batch number has been requested.; Sender's Comments: Based on temporal association, a possible contributory role of suspect BNT162B2 cannot be excluded for reported events shortness of breath, chest pain, runny nose, dry cough and dizzy.  The patient's underlying ongoing shortness of breath and psychiatric disorder treated by sertraline may also be contributory. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Pulmonary function test abnormal, Restrictive pulmonary disease
Clinical narrative: Persistent shortness of breath; Chest pain; Runny nose; Dry cough; Dizzy; This is a spontaneous report from a contactable other healthcare professional (patient). A 37-year-old female patient received the second dose of bnt162b2 (COVID-19 vaccine, brand: Pfizer) via an unspecified route of administration in right arm, on 07Jan2021 09:15 at a single dose for COVID-19 immunization in a hospital. Medical history included narcolepsy from an unknown date and unknown if ongoing and ongoing persistent shortness of breath from an unknown date. No known allergy. Concomitant medication included armodafinil, sertraline hydrochloride (ZOLOFT), and dextroamphetamine (DEXAMFETAMINE). The patient previously received the first dose of bnt162b2 on 21Dec2020 12:00 in right arm for COVID-19 immunization at age 37 years old. The patient had no COVID prior to vaccination. On 07Jan2021, the patient experienced shortness of breath, chest pain, runny nose, dry cough, dizzy. The patient had 2 ER visits and admission, and ongoing work up. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization for 1 day. The patient received albuterol and alprazolam (XANAX) as treatment. The patient underwent covid test post vaccination: Nasal swab on 11Jan2021 and on 12Jan2021 with both with result negative. The patient had not recovered from the events.  Information on the lot/batch number has been requested.; Sender's Comments: Based on temporal association, a possible contributory role of suspect BNT162B2 cannot be excluded for reported events shortness of breath, chest pain, runny nose, dry cough and dizzy.  The patient's underlying ongoing shortness of breath and psychiatric disorder treated by sertraline may also be contributory. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Condition aggravated, Cough, Dizziness, Dyspnoea
Clinical narrative: Persistent shortness of breath; Chest pain; Runny nose; Dry cough; Dizzy; This is a spontaneous report from a contactable other healthcare professional (patient). A 37-year-old female patient received the second dose of bnt162b2 (COVID-19 vaccine, brand: Pfizer) via an unspecified route of administration in right arm, on 07Jan2021 09:15 at a single dose for COVID-19 immunization in a hospital. Medical history included narcolepsy from an unknown date and unknown if ongoing and ongoing persistent shortness of breath from an unknown date. No known allergy. Concomitant medication included armodafinil, sertraline hydrochloride (ZOLOFT), and dextroamphetamine (DEXAMFETAMINE). The patient previously received the first dose of bnt162b2 on 21Dec2020 12:00 in right arm for COVID-19 immunization at age 37 years old. The patient had no COVID prior to vaccination. On 07Jan2021, the patient experienced shortness of breath, chest pain, runny nose, dry cough, dizzy. The patient had 2 ER visits and admission, and ongoing work up. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization for 1 day. The patient received albuterol and alprazolam (XANAX) as treatment. The patient underwent covid test post vaccination: Nasal swab on 11Jan2021 and on 12Jan2021 with both with result negative. The patient had not recovered from the events.  Information on the lot/batch number has been requested.; Sender's Comments: Based on temporal association, a possible contributory role of suspect BNT162B2 cannot be excluded for reported events shortness of breath, chest pain, runny nose, dry cough and dizzy.  The patient's underlying ongoing shortness of breath and psychiatric disorder treated by sertraline may also be contributory. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test negative
Clinical narrative: Persistent shortness of breath; Chest pain; Runny nose; Dry cough; Dizzy; This is a spontaneous report from a contactable other healthcare professional (patient). A 37-year-old female patient received the second dose of bnt162b2 (COVID-19 vaccine, brand: Pfizer) via an unspecified route of administration in right arm, on 07Jan2021 09:15 at a single dose for COVID-19 immunization in a hospital. Medical history included narcolepsy from an unknown date and unknown if ongoing and ongoing persistent shortness of breath from an unknown date. No known allergy. Concomitant medication included armodafinil, sertraline hydrochloride (ZOLOFT), and dextroamphetamine (DEXAMFETAMINE). The patient previously received the first dose of bnt162b2 on 21Dec2020 12:00 in right arm for COVID-19 immunization at age 37 years old. The patient had no COVID prior to vaccination. On 07Jan2021, the patient experienced shortness of breath, chest pain, runny nose, dry cough, dizzy. The patient had 2 ER visits and admission, and ongoing work up. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization for 1 day. The patient received albuterol and alprazolam (XANAX) as treatment. The patient underwent covid test post vaccination: Nasal swab on 11Jan2021 and on 12Jan2021 with both with result negative. The patient had not recovered from the events.  Information on the lot/batch number has been requested.; Sender's Comments: Based on temporal association, a possible contributory role of suspect BNT162B2 cannot be excluded for reported events shortness of breath, chest pain, runny nose, dry cough and dizzy.  The patient's underlying ongoing shortness of breath and psychiatric disorder treated by sertraline may also be contributory. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Injection site hypoaesthesia, Injection site paraesthesia, Thirst
Clinical narrative: experienced numbness on right arm (vaccinated arm) to fingers; dizziness; This is a spontaneous report from a contactable nurse. A 56-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), intramuscular on arm right from 14Jan2021 08:30 to 14Jan2021 08:30 at SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 14Jan2021 08:35, 5 minutes after receiving vaccine experienced dizziness which lasted several hours, 10 minutes after receiving experienced numbness on right arm (vaccinated arm) to fingers which lasted into evening. The patient was given Benadryl by mouth, 25 mg. Tablet by nursing staff. The patient was not pregnant at the time of the report. Outcome of the events recovered with sequelae.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Vaccination site hypoaesthesia
Clinical narrative: experienced numbness on right arm (vaccinated arm) to fingers; dizziness; This is a spontaneous report from a contactable nurse. A 56-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), intramuscular on arm right from 14Jan2021 08:30 to 14Jan2021 08:30 at SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 14Jan2021 08:35, 5 minutes after receiving vaccine experienced dizziness which lasted several hours, 10 minutes after receiving experienced numbness on right arm (vaccinated arm) to fingers which lasted into evening. The patient was given Benadryl by mouth, 25 mg. Tablet by nursing staff. The patient was not pregnant at the time of the report. Outcome of the events recovered with sequelae.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Neck pain, Pain in jaw
Clinical narrative: pain on left side of head that extends from left temple to above and behind my left ear and down the back of her neck; chills; This is a spontaneous report from a contactable nurse (patient). A 48-year-old female patient received the first dose of bnt162b2 (lot number and expiration date were not reported), via an unspecified route of administration in the left arm on 04Jan2021 at 13:30 at a single dose in the workplace clinic for COVID-19 immunization. There were no medical history and concomitant medications. The patient did not have COVID prior to vaccination. The patient is not pregnant. The patient experienced sharp pain on left side of head that extends from left temple to above and behind my left ear and down the back of her neck on 05Jan2021 at 15:00. Sudden onset and fades over 10-60 minutes and reoccurs off and on throughout the day. Also have noticed chills at the same time, on 05Jan2021 at 15:00. The patient did not receive treatment for the events. Outcome of event chills was not recovered while recovered on 05Jan2021 for the other event.  Information on the lot/batch number has been requested.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Neck pain
Clinical narrative: pain on left side of head that extends from left temple to above and behind my left ear and down the back of her neck; chills; This is a spontaneous report from a contactable nurse (patient). A 48-year-old female patient received the first dose of bnt162b2 (lot number and expiration date were not reported), via an unspecified route of administration in the left arm on 04Jan2021 at 13:30 at a single dose in the workplace clinic for COVID-19 immunization. There were no medical history and concomitant medications. The patient did not have COVID prior to vaccination. The patient is not pregnant. The patient experienced sharp pain on left side of head that extends from left temple to above and behind my left ear and down the back of her neck on 05Jan2021 at 15:00. Sudden onset and fades over 10-60 minutes and reoccurs off and on throughout the day. Also have noticed chills at the same time, on 05Jan2021 at 15:00. The patient did not receive treatment for the events. Outcome of event chills was not recovered while recovered on 05Jan2021 for the other event.  Information on the lot/batch number has been requested.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test negative, Urticaria
Clinical narrative: Started breaking out in hives that within 30 mins covered 80-90% of my body.; This is a spontaneous report from a contactable other health care professional (patient). A 48-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EJ1686 and expiration date not provided), via an unspecified route of administration (left arm) first dose on 08Jan2021 15:00 at single dose for covid-19 immunisation. There was no medical history. The patient's concomitant medication included venlafaxine at 75 mg, 2x/day and unspecified medication. It was reported that the patient received the shot on Friday 08Jan2021 and no issue until Wednesday morning 13Jan2021 10:00, the patient started breaking out in hives that within 30 minutes covered 80-90% of my body. This resulted for the patient to visit physician office. The patient was treated with Steroid shot and pills, OTC Benadryl, and Pepcid. The outcome of the event was recovering. The patient was tested for Covid post vaccination on 14Jan2021 of Nasal swab and the result was negative.; Sender's Comments: Based on the available information, a causal relationship between the event urticaria and suspected vaccine BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Facial numbness and tingling; Facial numbness and tingling; This is a spontaneous report from a contactable other healthcare professional (HCP). A 40-years-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283), via an unspecified route of administration on the right arm on 08Jan2021 at 07:15 at a single dose for COVID-19 immunization. Medical history included anemia, Vitamin D deficiency, and known allergies to dairy and kiwi. Concomitant medication included iron (IRON), colecalciferol (VITAMIN D [COLECALCIFEROL]), zinc (ZINC), linum usitatissimum oil (FLAXSEED OIL [LINUM USITATISSIMUM OIL]), and cetirizine (CETIRIZINE). The patient had no other vaccine in four weeks. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EH9899, on the right arm on 19Dec2020 at 0745AM for COVID-19 immunization. The patient had no COVID prior vaccination and had not tested for COVID post vaccination. The patient experienced facial numbness and tingling on 08Jan2021 at 08:15. No treatment was administered for the events. The events resolved on an unknown date in Jan2021.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Heart rate increased, Nausea, Oropharyngeal pain
Clinical narrative: This is a spontaneous report from a contactable consumer. A 41-year-old female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EJ1685) on her left arm, via an unspecified route of administration on 08Jan2021 11:00 at a single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included spironolactone, loratadine (CLARITIN) and fish oil. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Dec2020 (first dose). The patient experienced severe chills with body shaking for 6 hours, excruciating headache, fever, sore throat, nausea and excessively high resting heart rate (over 100- usually under 60); all on 08Jan2021 20:30. No treatment was received for the events. The outcome of the events was recovered on 09Jan2021 02:30.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Tremor
Clinical narrative: This is a spontaneous report from a contactable consumer. A 41-year-old female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EJ1685) on her left arm, via an unspecified route of administration on 08Jan2021 11:00 at a single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included spironolactone, loratadine (CLARITIN) and fish oil. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Dec2020 (first dose). The patient experienced severe chills with body shaking for 6 hours, excruciating headache, fever, sore throat, nausea and excessively high resting heart rate (over 100- usually under 60); all on 08Jan2021 20:30. No treatment was received for the events. The outcome of the events was recovered on 09Jan2021 02:30.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Heart rate, Heart rate increased, Nausea
Clinical narrative: This is a spontaneous report from a contactable consumer. A 41-year-old female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EJ1685) on her left arm, via an unspecified route of administration on 08Jan2021 11:00 at a single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included spironolactone, loratadine (CLARITIN) and fish oil. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Dec2020 (first dose). The patient experienced severe chills with body shaking for 6 hours, excruciating headache, fever, sore throat, nausea and excessively high resting heart rate (over 100- usually under 60); all on 08Jan2021 20:30. No treatment was received for the events. The outcome of the events was recovered on 09Jan2021 02:30.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal pain, Pyrexia, Tremor
Clinical narrative: This is a spontaneous report from a contactable consumer. A 41-year-old female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EJ1685) on her left arm, via an unspecified route of administration on 08Jan2021 11:00 at a single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included spironolactone, loratadine (CLARITIN) and fish oil. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Dec2020 (first dose). The patient experienced severe chills with body shaking for 6 hours, excruciating headache, fever, sore throat, nausea and excessively high resting heart rate (over 100- usually under 60); all on 08Jan2021 20:30. No treatment was received for the events. The outcome of the events was recovered on 09Jan2021 02:30.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Bradyphrenia, Disorientation
Clinical narrative: low grade headache; minor disorientation that continues to persist; This is a spontaneous report from a contactable consumer. A 69-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EK9231, via an unspecified route of administration on 06Jan2021 14:00 at a single dose on the left arm for COVID-19 immunization. Medical history included heart rhythm (heart rate abnormal). Concomitant medication included metoprolol for heart rhythm and an unspecified statin. The patient received the first dose on 06Jan2021, and on 12Jan2021 he experienced low grade headache and minor disorientation that continues to persist. They started on the same day in the morning, unable to provide exact time. The low grade headache was lasting all day. He is scheduled to get the second dose on 27Jan2021 and was afraid of taking it due to these side effects. The outcome of the events was not recovered.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Disorientation, Headache
Clinical narrative: low grade headache; minor disorientation that continues to persist; This is a spontaneous report from a contactable consumer. A 69-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EK9231, via an unspecified route of administration on 06Jan2021 14:00 at a single dose on the left arm for COVID-19 immunization. Medical history included heart rhythm (heart rate abnormal). Concomitant medication included metoprolol for heart rhythm and an unspecified statin. The patient received the first dose on 06Jan2021, and on 12Jan2021 he experienced low grade headache and minor disorientation that continues to persist. They started on the same day in the morning, unable to provide exact time. The low grade headache was lasting all day. He is scheduled to get the second dose on 27Jan2021 and was afraid of taking it due to these side effects. The outcome of the events was not recovered.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Bradykinesia, Chills, Fatigue, Gait disturbance
Clinical narrative: shot at 11 pm 12:30 - achey. and BLURRED vision- could see more than 2 feet in front of me.  3:00- achey blurred vision worse.  7:00 - achey. chills.  Overnight. sick chills fever, soo much paing blurred vision.  6 am- could barely walk without clutching furniture . Could not move my injection arm more than 2 inches. Whole body and joints in exrtreme pain. Incapacitated all day. By friday. my body felt better. My vision not as blurry. but by the weekend I was back. I still feel like my vision is not quite back.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injected limb mobility decreased, Myalgia, Pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: shot at 11 pm 12:30 - achey. and BLURRED vision- could see more than 2 feet in front of me.  3:00- achey blurred vision worse.  7:00 - achey. chills.  Overnight. sick chills fever, soo much paing blurred vision.  6 am- could barely walk without clutching furniture . Could not move my injection arm more than 2 inches. Whole body and joints in exrtreme pain. Incapacitated all day. By friday. my body felt better. My vision not as blurry. but by the weekend I was back. I still feel like my vision is not quite back.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vision blurred
Clinical narrative: shot at 11 pm 12:30 - achey. and BLURRED vision- could see more than 2 feet in front of me.  3:00- achey blurred vision worse.  7:00 - achey. chills.  Overnight. sick chills fever, soo much paing blurred vision.  6 am- could barely walk without clutching furniture . Could not move my injection arm more than 2 inches. Whole body and joints in exrtreme pain. Incapacitated all day. By friday. my body felt better. My vision not as blurry. but by the weekend I was back. I still feel like my vision is not quite back.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Arthralgia, Chills, Gait disturbance, Injected limb mobility decreased
Clinical narrative: shot at 11 pm 12:30 - achey. and BLURRED vision- could see more than 2 feet in front of me.  3:00- achey blurred vision worse.  7:00 - achey. chills.  Overnight. sick chills fever, soo much paing blurred vision.  6 am- could barely walk without clutching furniture . Could not move my injection arm more than 2 inches. Whole body and joints in exrtreme pain. Incapacitated all day. By friday. my body felt better. My vision not as blurry. but by the weekend I was back. I still feel like my vision is not quite back.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Malaise, Pain, Pyrexia, Vision blurred
Clinical narrative: shot at 11 pm 12:30 - achey. and BLURRED vision- could see more than 2 feet in front of me.  3:00- achey blurred vision worse.  7:00 - achey. chills.  Overnight. sick chills fever, soo much paing blurred vision.  6 am- could barely walk without clutching furniture . Could not move my injection arm more than 2 inches. Whole body and joints in exrtreme pain. Incapacitated all day. By friday. my body felt better. My vision not as blurry. but by the weekend I was back. I still feel like my vision is not quite back.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Pain, Pain in extremity, Pyrexia
Clinical narrative: This is a spontaneous report from a contactable other healthcare professional (patient).  A 59-year-old female patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EK4176), via an unspecified route of administration in left arm on 14Jan2021 10:15 at single dose for COVID-19 immunization. Facility type vaccine was workplace clinic. Medical history included ''Known allergies: Penicillin; Bee stings; Red meat; seasonal''. No COVID prior vaccination. Concomitant medications included estrogens conjugated, medroxyprogesterone acetate (PREMPRO), ergocalciferol (VITAMIN D). The patient previously received first dose bnt162b2 (lot number= EH9899) via an unspecified route of administration in left arm at the age of 59-year-old on 28Dec2020 10:15 for COVID-19 immunization. The patient experienced severe body aches, severe headache, arm sore on 14Jan2021 21:00. No treatment received for the events severe body aches, severe headache, arm sore. No COVID tested post vaccination. The patient not received other vaccine in four weeks. Patient was not pregnant. The outcome of events severe body aches, severe headache, arm sore was recovering. The outcome of other event was unknown.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Inappropriate schedule of product administration, Pain, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable other healthcare professional (patient).  A 59-year-old female patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EK4176), via an unspecified route of administration in left arm on 14Jan2021 10:15 at single dose for COVID-19 immunization. Facility type vaccine was workplace clinic. Medical history included ''Known allergies: Penicillin; Bee stings; Red meat; seasonal''. No COVID prior vaccination. Concomitant medications included estrogens conjugated, medroxyprogesterone acetate (PREMPRO), ergocalciferol (VITAMIN D). The patient previously received first dose bnt162b2 (lot number= EH9899) via an unspecified route of administration in left arm at the age of 59-year-old on 28Dec2020 10:15 for COVID-19 immunization. The patient experienced severe body aches, severe headache, arm sore on 14Jan2021 21:00. No treatment received for the events severe body aches, severe headache, arm sore. No COVID tested post vaccination. The patient not received other vaccine in four weeks. Patient was not pregnant. The outcome of events severe body aches, severe headache, arm sore was recovering. The outcome of other event was unknown.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Cough, Headache, Malaise, Myalgia
Clinical narrative: I have felt minor chills; muscle aches; headaches; general unwell/unease; general unwell/unease; minor sore throat; coughing; This is a spontaneous report from a contactable healthcare professional (patient). A 25-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on left arm on 05Jan2021 07:45 at single dose for COVID-19 immunization.  Facility type vaccine was in workplace clinic. No other vaccine in four weeks. Medical history included chronic right sided tightness/discomfort. The patient was not pregnant at the time of vaccination. The patient had no known allergies. Concomitant medications included (other medications in 2 weeks) included Magnesium, Iodine, dexpanthenol;nicotinamide;pyridoxine hydrochloride;riboflavin;thiamine hydrochloride (VITEX) and colecalciferol (VITAMIN D). On the 5th of Jan2021 at around 16:00, the patient experienced a minor sore throat and some coughing. From the 11th of Jan2021 through the present day I have felt minor chills, muscle aches, headaches, and general unwell/unease. There was no treatment for the events. No COVID prior vaccination. The patient was tested for COVID post vaccination, tests included COVID-19 Rapid Antigen Test (COVID test type post vaccination=Nasal Swab) and COVID-19 IgG/IgM Antibody Test (COVID test type post vaccination=Blood test) both done on 07Jan2021 and both with negative results. The outcome of the events was recovering.  Information on the lot/batch number has been requested.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat irritation
Clinical narrative: I have felt minor chills; muscle aches; headaches; general unwell/unease; general unwell/unease; minor sore throat; coughing; This is a spontaneous report from a contactable healthcare professional (patient). A 25-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on left arm on 05Jan2021 07:45 at single dose for COVID-19 immunization.  Facility type vaccine was in workplace clinic. No other vaccine in four weeks. Medical history included chronic right sided tightness/discomfort. The patient was not pregnant at the time of vaccination. The patient had no known allergies. Concomitant medications included (other medications in 2 weeks) included Magnesium, Iodine, dexpanthenol;nicotinamide;pyridoxine hydrochloride;riboflavin;thiamine hydrochloride (VITEX) and colecalciferol (VITAMIN D). On the 5th of Jan2021 at around 16:00, the patient experienced a minor sore throat and some coughing. From the 11th of Jan2021 through the present day I have felt minor chills, muscle aches, headaches, and general unwell/unease. There was no treatment for the events. No COVID prior vaccination. The patient was tested for COVID post vaccination, tests included COVID-19 Rapid Antigen Test (COVID test type post vaccination=Nasal Swab) and COVID-19 IgG/IgM Antibody Test (COVID test type post vaccination=Blood test) both done on 07Jan2021 and both with negative results. The outcome of the events was recovering.  Information on the lot/batch number has been requested.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Chills, Cough, Headache, Malaise
Clinical narrative: I have felt minor chills; muscle aches; headaches; general unwell/unease; general unwell/unease; minor sore throat; coughing; This is a spontaneous report from a contactable healthcare professional (patient). A 25-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on left arm on 05Jan2021 07:45 at single dose for COVID-19 immunization.  Facility type vaccine was in workplace clinic. No other vaccine in four weeks. Medical history included chronic right sided tightness/discomfort. The patient was not pregnant at the time of vaccination. The patient had no known allergies. Concomitant medications included (other medications in 2 weeks) included Magnesium, Iodine, dexpanthenol;nicotinamide;pyridoxine hydrochloride;riboflavin;thiamine hydrochloride (VITEX) and colecalciferol (VITAMIN D). On the 5th of Jan2021 at around 16:00, the patient experienced a minor sore throat and some coughing. From the 11th of Jan2021 through the present day I have felt minor chills, muscle aches, headaches, and general unwell/unease. There was no treatment for the events. No COVID prior vaccination. The patient was tested for COVID post vaccination, tests included COVID-19 Rapid Antigen Test (COVID test type post vaccination=Nasal Swab) and COVID-19 IgG/IgM Antibody Test (COVID test type post vaccination=Blood test) both done on 07Jan2021 and both with negative results. The outcome of the events was recovering.  Information on the lot/batch number has been requested.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Oropharyngeal pain, SARS-CoV-2 antibody test, SARS-CoV-2 test
Clinical narrative: I have felt minor chills; muscle aches; headaches; general unwell/unease; general unwell/unease; minor sore throat; coughing; This is a spontaneous report from a contactable healthcare professional (patient). A 25-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on left arm on 05Jan2021 07:45 at single dose for COVID-19 immunization.  Facility type vaccine was in workplace clinic. No other vaccine in four weeks. Medical history included chronic right sided tightness/discomfort. The patient was not pregnant at the time of vaccination. The patient had no known allergies. Concomitant medications included (other medications in 2 weeks) included Magnesium, Iodine, dexpanthenol;nicotinamide;pyridoxine hydrochloride;riboflavin;thiamine hydrochloride (VITEX) and colecalciferol (VITAMIN D). On the 5th of Jan2021 at around 16:00, the patient experienced a minor sore throat and some coughing. From the 11th of Jan2021 through the present day I have felt minor chills, muscle aches, headaches, and general unwell/unease. There was no treatment for the events. No COVID prior vaccination. The patient was tested for COVID post vaccination, tests included COVID-19 Rapid Antigen Test (COVID test type post vaccination=Nasal Swab) and COVID-19 IgG/IgM Antibody Test (COVID test type post vaccination=Blood test) both done on 07Jan2021 and both with negative results. The outcome of the events was recovering.  Information on the lot/batch number has been requested.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: injection site pain & swelling; injection site pain & swelling; Fever (99.5 max); chills; headache; This is a spontaneous report from a contactable nurse (patient herself). A 45-year-old female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 12Jan2021 11:30 in right arm at single dose for covid-19 immunization. The patient was known allergies: wheat. Other medications in two weeks included multivitamin and calcium. The patient previously took Influenza vaccine, norethisterone (NORETHINDRONE) and experienced known allergies. No other vaccine in four weeks were taken. Facility type vaccine was workplace clinic. The patient had no COVID prior vaccination and was not tested COVID post vaccination. The patient experienced injection site pain & swelling, fever (99.5 max), chills, headache on 12Jan2021 21:00. Outcome of events were recovered on Jan2021. No treatment was received for the events.   Information on the lot/batch number has been requested.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Headache, Pyrexia, Vaccination site pain
Clinical narrative: injection site pain & swelling; injection site pain & swelling; Fever (99.5 max); chills; headache; This is a spontaneous report from a contactable nurse (patient herself). A 45-year-old female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 12Jan2021 11:30 in right arm at single dose for covid-19 immunization. The patient was known allergies: wheat. Other medications in two weeks included multivitamin and calcium. The patient previously took Influenza vaccine, norethisterone (NORETHINDRONE) and experienced known allergies. No other vaccine in four weeks were taken. Facility type vaccine was workplace clinic. The patient had no COVID prior vaccination and was not tested COVID post vaccination. The patient experienced injection site pain & swelling, fever (99.5 max), chills, headache on 12Jan2021 21:00. Outcome of events were recovered on Jan2021. No treatment was received for the events.   Information on the lot/batch number has been requested.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site swelling
Clinical narrative: injection site pain & swelling; injection site pain & swelling; Fever (99.5 max); chills; headache; This is a spontaneous report from a contactable nurse (patient herself). A 45-year-old female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 12Jan2021 11:30 in right arm at single dose for covid-19 immunization. The patient was known allergies: wheat. Other medications in two weeks included multivitamin and calcium. The patient previously took Influenza vaccine, norethisterone (NORETHINDRONE) and experienced known allergies. No other vaccine in four weeks were taken. Facility type vaccine was workplace clinic. The patient had no COVID prior vaccination and was not tested COVID post vaccination. The patient experienced injection site pain & swelling, fever (99.5 max), chills, headache on 12Jan2021 21:00. Outcome of events were recovered on Jan2021. No treatment was received for the events.   Information on the lot/batch number has been requested.